Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Post by GoldenInvestoron Jun 10, 2020 3:22pm

103 Views

Post# 31135052

Paladin's path to build took how many years?

Didn't it take more than 6 years before they began to have lots of revenue coming in?

did paladin have to deal with a global pandemic?

did paladin have a division that generated ~$25 million quarterly?

what did Goodman . Say at the beginning? This will happen overnight , or, it will follow the similar trajectory as paladin ?

that took.a lot of years pre take off?

it looks like they are building a bigger base that will launch sooner than paladin did, but it may take some time to get ripping higher!

- but numbers and compounding will soon be evident!!

did paladin have $400 million to spend to further acquisitions?

Bullboard Posts

3 Mid-Sized Stocks to Consider This Season